Search

Your search keyword '"Alexander D. Miras"' showing total 129 results

Search Constraints

Start Over You searched for: Author "Alexander D. Miras" Remove constraint Author: "Alexander D. Miras"
129 results on '"Alexander D. Miras"'

Search Results

1. Obesity Treatments to Improve Type 1 Diabetes (OTID): a randomized controlled trial of the combination of glucagon-like peptide 1 analogues and sodium-glucose cotransporter 2 inhibitors—protocol for Obesity Treatments to Improve Type 1 Diabetes (the OTID trial)

2. Obesity surgery and neural correlates of human eating behaviour: A systematic review of functional MRI studies

3. Vertical sleeve gastrectomy normalizes circulating glucocorticoid levels and lowers glucocorticoid action tissue-selectively in mice

4. Metabolic syndrome is associated with prostate enlargement: a systematic review, meta-analysis, and meta-regression on patients with lower urinary tract symptom factors

5. Measurement of glomerular filtration rate in patients undergoing obesity surgery

6. Mechanisms Underlying Type 2 Diabetes Remission After Metabolic Surgery

7. Rats Fed Diets with Different Energy Contribution from Fat Do Not Differ in Adiposity

8. Tripeptide gut hormone infusion does not alter food preferences or sweet taste function in volunteers with obesity and prediabetes/diabetes but promotes restraint eating: A secondary analysis of a randomized single‐blind placebo‐controlled study

9. Author response for 'Tripeptide gut hormone infusion does not alter food preferences or sweet taste function in volunteers with obesity and pre‐diabetes/diabetes but promotes restraint eating: A secondary analysis of a randomised single‐blind placebo‐controlled study'

10. Mechanisms of Weight Loss After Obesity Surgery

11. Weight Loss by Low-Calorie Diet Versus Gastric Bypass Surgery in People With Diabetes Results in Divergent Brain Activation Patterns: A Functional MRI Study

12. The efficacy of GLP-1RAs for the management of postprandial hypoglycemia following bariatric surgery: a systematic review

13. Reversal and remission of T2DM - an update for practitioners

14. Risk of Harm from Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients Pre or Post Bariatric Surgery

15. Bariatric Surgical Services Within a Pandemic Can Continue Safely: the Initial Experience of a UK Centre of Excellence

16. Hypothalamic integrity is necessary for sustained weight loss after bariatric surgery: A prospective, cross-sectional study

18. 20 Validation of WatchPAT 300 for pre-operative of OSA screening in patients undergoing bariatric surgery

20. Duodenal-Jejunal Bypass Liner for the management of Type 2 Diabetes Mellitus and Obesity: A Multicenter Randomized Controlled Trial

21. Mechanisms of action of duodenal mucosal resurfacing in insulin resistant women with polycystic ovary syndrome

22. Author response for 'The effects of GLP ‐1 receptor agonists on histopathological and secondary biomarkers of non‐alcoholic steatohepatitis: A systematic review and meta‐analysis'

23. Effects of glucagon-like peptide-1 receptor agonists on histopathological and secondary biomarkers of non-alcoholic steatohepatitis: A systematic review and meta-analysis

24. Liraglutide 3.0 mg within a NHS Tier-3/4 weight management service results in similar weight loss compared to regulatory trials - The LIPOSAX first UK real-world evidence study

25. Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial

26. Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial

27. The effect of a duodenal-jejunal bypass liner on lipid profile and blood concentrations of long chain polyunsaturated fatty acids

28. Weight loss with bariatric surgery or behaviour modification and the impact on female obesity-related urine incontinence: A comprehensive systematic review and meta-analysis

29. Simple tool to prioritize access to bariatric surgery for people living with obesity during the COVID-19 pandemic

30. Metabolic surgery versus conventional therapy in type 2 diabetes

32. O33 Duodenal-jejunal bypass liner therapy (Endobarrier®) causes reductions in plasma trimethylamine-N-oxide in obese patients with diabetes

34. Author response for 'Imperial Satiety Protocol ‐ a new non‐surgical weight‐loss programme, delivered in a healthcare setting, produces improved clinical outcomes for people with obesity'

35. Investigation of the mechanism of action of duodenal mucosal resurfacing in insulin resistant women with polycystic ovarian syndrome. the DOMINO multicentre randomised controlled trial

36. Bariatric surgery normalizes circulating glucocorticoid levels and lowers glucocorticoid action tissue-selectively in mice

37. Imperial Satiety Protocol: A new non-surgical weight-loss programme, delivered in a health care setting, produces improved clinical outcomes for people with obesity

38. Roux-en-Y Gastric Bypass Increases Glycemic Variability and Time in Hypoglycemia in Patients With Obesity and Prediabetes or Type 2 Diabetes: A Prospective Cohort Study

39. A duodenal sleeve bypass device added to intensive medical therapy for obesity with type 2 diabetes: a RCT

40. Liraglutide downregulates the expression of miRNA-424 in patients with obesity

41. The effect of standard versus longer intestinal bypass on glp-1 regulation and glucose metabolism in patients with type 2 diabetes undergoing roux-en-y gastric bypass. The long-limb study

44. Brain Feeding Circuits after Roux-en-Y Gastric Bypass

45. Chemerin induces endothelial cell inflammation: activation of nuclear factor-kappa beta and monocyte-endothelial adhesion

46. High Body Adiposity Drives Glucose Intolerance and Increases Cardiovascular Risk in Normoglycemic Subjects

47. New to Research

48. Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass

49. What is the role of bariatric surgery in the management of obesity?

50. Sa1961 ONE YEAR OF DUODENAL-JEJUNAL BYPASS LINER THERAPY (ENDOBARRIER®) LEADS TO SIGNIFICANT CHANGES IN LIVER BIOCHEMISTRY ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE

Catalog

Books, media, physical & digital resources